Category: Hematology

Hulpgids na diagnose AML

Welke behandelingen zijn er en wat past bij u? Bij u is acute myeloïde leukemie (AML) vastgesteld. Dat kan betekenen dat er veel op u en uw naasten afkomt. Uw arts geeft u zoveel mogelijk informatie over wat u kunt verwachten. Deze brochure geeft een overzicht van die informatie: wat is AML, welke behandelingen zijn er…

Read the full article

A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP

A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP Coppo et al. Blood 2021; 137(6): 733–742. Select your desired language: English German | Deutsch Spanish | Español French | Français Italian | Italiano Japanese | 日本語 English Access ePrint German | Deutsch Available Soon Spanish | Español Available Soon French…

Read the full article

Abstract 177 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

177 – CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma Abstract Presentation Abstract View author list and disclosures Author(s): Deepu Madduri, MD1*, Jesus G. Berdeja, MD2, Saad Z. Usmani, MD, MBBS, MBA3, Andrzej Jakubowiak, MD, PhD4, Mounzer Agha, MD5, Adam D. Cohen,…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

141 – Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial Abstract Presentation Abstract View author list and disclosures Author(s): Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini*, Monica Galli*, Angelo Belotti, MD*, Elena Zamagni, MD*, Luca Bertamini, MD*, Renato Zambello*, Micol Quaresima*, Giovanni De Sabbata*, Giuseppe Pietrantuono*, Mattia D’Agostino,…

Read the full article

An abstract from the 62nd ASH® Annual Meeting & Exposition, courtesy of Gilead

1187 – Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel) Abstract Presentation Slides Abstract View author list and disclosures Author(s): Caron Jacobson, MD, MMSc1, Frederick L. Locke, MD2, Armin Ghobadi, MD3, David B. Miklos, MD, PhD4, Lazaros J. Lekakis, MD5*, Olalekan O.…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Jazz Pharmaceuticals (MSL)

2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…

Read the full article

Abstract 143 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

143 – Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial Abstract Presentation Abstract View author list and disclosures Author(s): Aurore Perrot, MD, PhD, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, MD, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro, Olivier Decaux, Karim Belhadj, MD, Mohamad Mohty,…

Read the full article

A collection of abstracts from the 62nd ASH® Annual Meeting & Exposition, courtesy of Jazz Pharmaceuticals (KAM)

2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…

Read the full article

Abstract 1369 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Celgene

1369 – Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study Abstract Presentation Abstract View author list and disclosures Author(s): Benjamin Diamond, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Eric L Smith, MD, PhD, Urvi A Shah, MD,…

Read the full article

Abstract 984 from the 62nd ASH® Annual Meeting & Exposition, courtesy of Incyte

984 – Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Results of Ponalfil Clinical Trial after Completion of Recruitment Abstract Presentation Slides Abstract View author list and disclosures Author(s): Josep-Maria Ribera, Olga García, Pau Montesinos, MD, PhD, Pilar Martinez, MD, Jordi Esteve, MD, PhD, Daniel Esteban, María José Moreno,…

Read the full article